LMAT vs TER · P/E 35, rev $219.9M vs P/E 76, rev $2.82B
LeMaitre Vascular Inc (LMAT) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the LMAT and TER stock pages for the full models.
Not investment advice.